ReadytoUse Therapeutic Food (RUTF)

What is RUTF?

ReadytoUse Therapeutic Food (RUTF) is a nutrientdense, shelfstable paste that provides the calories, proteins, fats, vitamins and minerals needed to treat severe acute malnutrition (SAM) in children. It is designed to be eaten directly from the packet, requires no cooking, water, or refrigeration, and delivers a therapeutic dose of energy (typically 5001000kcal per 100g).

Key Ingredients

Although formulations can vary, most RUTF products share a core set of components:

• Peanut paste provides highquality protein and healthy fats.
• Milk powder (skimmed or whey) adds essential amino acids, calcium and improves taste.
• Sugar (sucrose or glucose syrup) supplies quickrelease energy and makes the paste palatable.
• Vegetable oil boosts the caloric density (5kcalg).
• Micronutrient premix a blend of vitamins (A, D, E, K, Bcomplex, C) and minerals (zinc, iron, calcium, etc.) to correct deficiencies.
• Stabilizers and emulsifiers ensure a smooth, homogeneous texture that does not separate.

All ingredients are roasted or heattreated to destroy pathogens, which makes the final product safe for use in areas with limited water quality.

How RUTF Works

RUTF supplies the body with a balanced mix of macronutrients and micronutrients that are rapidly absorbed. The highenergy density promotes weight gain of at least 5gkgday, the benchmark for successful SAM treatment. Because it can be consumed without preparation, caregivers can give it to children throughout the day, encouraging continuous intake and minimizing the risk of interruption.

Clinical trials have shown that children receiving RUTF recover faster and with fewer complications than those treated with traditional inpatient therapeutic milk formulas, which often require hospital stays, clean water and trained staff.

Benefits Over Conventional Treatments

• Communitybased care treatment can be delivered at home or in outpatient clinics, reducing the burden on hospitals.
• Reduced mortality timely use of RUTF cuts death rates from SAM by up to 80%.
• Costeffective one 92g packet (500kcal) costs roughly US0.300.40; the total cost per cured child is often lower than inpatient care.
• Ease of distribution lightweight, nonperishable, and ready for immediate use.
• Cultural acceptance the sweet, peanutflavored taste is generally wellliked by children in many regions.

WHO Guidelines for RUTF Use

The World Health Organization recommends RUTF for children aged 6months to 5years who meet any of the following criteria:

• Weightforheight Zscore <3SD.
• Midupperarm circumference (MUAC)<115mm.
• Presence of nutritional oedema.

Therapeutic protocols typically call for 150200kcalkgday, delivered in 23 daily packets. Treatment continues until the child reaches a weightforheight Zscore >2SD or a MUAC125mm, whichever occurs first.

Production and Quality Assurance

Manufacturing RUTF follows strict Good Manufacturing Practices (GMP). Key steps include:

1. Roasting peanuts to eliminate aflatoxinproducing fungi.
2. Testing raw ingredients for microbial load, aflatoxin levels, and metal contaminants.
3. Grinding peanuts to a fine paste under controlled temperature.
4. Homogenising the paste with milk powder, oil, sugar and micronutrient premix.
5. Filling packets in a cleanroom environment and sealing them hermetically.
6. Conducting batchwise stability testing (shelf life usually 24months).

Many countries have national quality control laboratories that verify each batch against WHO specifications before the product enters the public health supply chain.

Challenges and Considerations

While RUTF has transformed SAM treatment, several challenges remain:

• Aflatoxin contamination peanuts are prone to aflatoxins; rigorous sourcing and testing are essential.
• Allergy risk peanut allergy, though rare in many lowincome settings, may limit use in specific populations.
• Supply chain logistics remote areas may face transport delays; bulk packaging and local production can mitigate this.
• Cultural preferences alternative bases (e.g., soy, millet, rice) are being explored for communities with peanut aversion.
• Cost sustainability reliance on donor funding can be unstable; integrating RUTF into national health budgets is a longterm goal.

Innovations and Future Directions

Research is expanding the RUTF palette:

• Peanutfree formulations using chickpea, lentil or soy flours for allergysensitive groups.
• Higherprotein variants that increase leanmass gain during recovery.
• Locally produced RUTF empowering regional manufacturers reduces import costs and strengthens local economies.
• Smart packaging with temperature indicators to guarantee product integrity.

These advances aim to make therapeutic feeding more inclusive, affordable, and adaptable to diverse contexts.

How Communities Can Support RUTF Programs

Successful implementation relies on coordinated effort:

• Health workers receive training on screening, dosage calculation, and monitoring of side effects.
• Caregivers educated on proper storage (cool, dry place), feeding frequency, and the importance of completing the full course.
• Local NGOs assist with distribution, community outreach, and data collection.
• Governments incorporate RUTF into national nutrition policies and secure sustainable financing.

Community awareness campaigns that explain why RUTF is not a regular snack but a lifesaving medical food dramatically improve adherence.

Key Resources

• World Health Organization Guidelines for the Management of Severe Acute Malnutrition
• UNICEF ReadytoUse Therapeutic Food page
• International Centre for Research in Organic Food Processing research papers on RUTF formulation
• Global Alliance for Improved Nutrition (GAIN) resources on local production models